Sustained virologic response by direct‐acting antivirals suppresses skeletal muscle loss in hepatitis C virus infection

Background and Aim Although chronic liver disease is associated with secondary sarcopenia, the effect of primary disease treatment (hepatitis C virus elimination) on the skeletal muscle is unclear. This study aimed to determine the effect of a sustained virologic response at 24 weeks following direct‐acting antiviral therapy on the skeletal muscle in hepatitis C virus‐infected patients. Methods Hepatitis C virus‐infected patients treated with...